NasdaqCM - Nasdaq Real Time Price USD
Dyadic International, Inc. (DYAI)
1.2296
+0.0296
+(2.47%)
As of 11:36:32 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOSE ARINDAM Director | Conversion of Exercise of derivative security | Jan 2, 2025 | 50,759 |
| BUCKLAND BARRY JOHN Director | Conversion of Exercise of derivative security | Jun 11, 2024 | 38,967 |
| EMALFARB MARK A Chief Executive Officer | Stock Award(Grant) | Jan 2, 2025 | 4,730,060 |
| HAZELTON JOSEPH P Chief Operating Officer | Stock Award(Grant) | Jan 2, 2025 | 129,340 |
| HERBST SETH J. M.D. Director | Conversion of Exercise of derivative security | Jan 6, 2025 | 180,759 |
| KAYE JACK Director | Conversion of Exercise of derivative security | Mar 5, 2025 | 59,649 |
| LUCY PATRICK K Director | Conversion of Exercise of derivative security | Jan 2, 2025 | 50,759 |
| RAWSON PING WANG Chief Financial Officer | Stock Award(Grant) | Jan 2, 2025 | 140,993 |
| TARNOK MICHAEL P Director | Conversion of Exercise of derivative security | Jan 2, 2025 | 270,257 |
| TCHELET RONEN Officer | Stock Award(Grant) | Jan 2, 2025 | 32,833 |
Related Tickers
MCET MultiCell Technologies, Inc.
0.0000
0.00%
QBIO Q BioMed Inc.
0.0001
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
5.88
+1.38%
THAR Tharimmune, Inc.
1.2350
-0.40%
EXOZ eXoZymes, Inc.
11.68
-13.71%
RNTX Rein Therapeutics Inc.
1.7800
-2.20%
ACTU Actuate Therapeutics, Inc. Common stock
8.88
-1.39%
BRTX BioRestorative Therapies, Inc.
1.7000
-1.72%
ORGS Orgenesis Inc.
2.4900
+12.67%
PMVP PMV Pharmaceuticals, Inc.
1.0700
0.00%